Business
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the H.C. Wainwright 4th Annual Bioconnect Investor Conference, the 2026 Stifel Virtual Targeted Oncology Forum, and the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA. With an initial fo
About this update from Foghorn Therapeutics Inc.
[{"type":"image","alt":"Foghorn Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Foghorn Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/c48e0461026ebce223e5a31638f2e086"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lZQs0UgtmfP013MY5QJUpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNQ--/https://media.zenfs.com/en/globenewswire.com/c48e0461026ebce223e5a31638f2e086","width":300,"height":75},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/lZQs0UgtmfP013MY5QJUpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNQ--/https://media.zenfs.com/en/globenewswire.com/c48e0461026ebce223e5a31638f2e086","width":300,"height":75}},"lazy":false},{"type":"text","content":"WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the H.C. Wainwright 4th Annual Bioconnect Investor Conference, the 2026 Stifel Virtual Targeted Oncology Forum, and the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.","length":691,"tagName":"p"},{"type":"text","content":"H.C. Wainwright 4th Annual Bioconnect Investor Conference at Nasdaq","length":67,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Management will participate in one-on-one meetings on May 19, 2026","length":66,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":66,"olType":false},{"type":"text","content":"2026 Stifel Virtual Targeted Oncology Forum ","length":43,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Presentation: Wednesday, May 20, 2026, at 11:00 a.m. EDT","length":56,"tagName":"p"}]},{"val":[{"type":"text","content":"Presenter: Adrian Gottschalk, President and Chief Executive Officer","length":67,"tagName":"p"}]},{"val":[{"type":"text","content":"Management will also participate in one-on-one meetings","length":55,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":178,...